KNK423
KNK423 is a specific heat shock protein (HSP) synthesis inhibitor. KNK423 improves the efficiency of Amphotericin B in inhibiting resistant Aspergillus terreus by blocking HSP70. KNK423 can be used in cancer and bacterial infection research[1][2].
Product Specifications
CAS Number
1859-42-3
UNSPSC
12352005
Hazard Statement
H315-H319
Target
HSP
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/knk423.html
Solubility
10 mM in DMSO
Smiles
O=C1NCC/C1=C\C2=CC=C3OCOC3=C2
Molecular Formula
C12H11NO3
Molecular Weight
217.22
Precautions
P264-P280-P302+P352-P362+P364
References & Citations
[1]Koishi M, et al. The effects of KNK437, a novel inhibitor of heat shock protein synthesis, on the acquisition of thermotolerance in a murine transplantable tumor in vivo. Clin Cancer Res. 2001 Jan;7 (1) :215-9.|[2]Blatzer M, et al. Blocking Hsp70 enhances the efficiency of amphotericin B treatment against resistant Aspergillus terreus strains. Antimicrob Agents Chemother. 2015 Jul;59 (7) :3778-88.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
B1098-01K 50 µg
Endophilin B1 (SH3 Domain-containing GRB2-like Protein B1, Bax-interacting Factor 1, Bif-1, SH3GLB1, KIAA0491, CGI-61) discontinued
Sign In for Pricing
View Details 
